Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RICE: Reduced-Intensity Conditioning Allogeneic HSCT in Children
NCT00750126Phase 2Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Apr 2007
- Primary completion
- Apr 2009
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine, busulfan, antithymocyte globulin rabbit in hematologic neoplasm, solid tumor, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Status: unknown.
02
Drugs
fludarabinebusulfanantithymocyte globulin rabbit
03
Conditions
hematologic neoplasmsolid tumor
Beyond the preview
Go deeper on NCT00750126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00750126.